Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China flag China · Delayed Price · Currency is CNY
28.71
-0.40 (-1.37%)
At close: Feb 12, 2026

SHE:301584 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
299.65228.31196.3174.28166.94159.67
Depreciation & Amortization
82.782.757.738.9929.054.78
Other Amortization
21.8621.8612.815.964.324.58
Loss (Gain) From Sale of Assets
-0.49-0.49-0.23-0.330.03-1.79
Asset Writedown & Restructuring Costs
000.28-18.2519.68
Loss (Gain) From Sale of Investments
----0.73--0.42
Provision & Write-off of Bad Debts
14.4514.459.3631.0613.9527.79
Other Operating Activities
1,309237.45199.13116.2747.4411.02
Change in Accounts Receivable
-752.03-752.03-744.35-351.09275.23-1,125
Change in Inventory
-1,000-1,000-719.35-631.22-756.46-121.08
Change in Accounts Payable
1,3401,340612.836.73-515.741,025
Change in Other Net Operating Assets
1.391.393.483.81-8.97
Operating Cash Flow
1,308164.48-374.57-627.89-732.97-1.2
Capital Expenditures
-120.56-121.05-82.39-33.5-10.18-6.95
Sale of Property, Plant & Equipment
0.660.740.050.030.0610.78
Cash Acquisitions
---11.94---3.05
Other Investing Activities
-2.39---8.11--
Investing Cash Flow
-122.29-120.31-94.28-41.58-10.120.78
Long-Term Debt Issued
-4,4574,2742,8731,807145.35
Long-Term Debt Repaid
--4,178-3,181-1,592-688-0.03
Net Debt Issued (Repaid)
-468.17278.851,0931,2801,119145.33
Common Dividends Paid
-127.02-151.89-133.61-142.35-149.11-99.2
Other Financing Activities
42.19-3.17-47-24.88-364.85-5.15
Financing Cash Flow
-244.3123.8912.431,113604.9740.98
Foreign Exchange Rate Adjustments
-0.680-0-0.010.01-0
Miscellaneous Cash Flow Adjustments
00-0-0--
Net Cash Flow
940.37167.96443.58443.65-138.1240.56
Free Cash Flow
1,18743.42-456.96-661.39-743.15-8.15
Free Cash Flow Margin
6.15%0.24%-2.96%-5.57%-7.41%-0.10%
Free Cash Flow Per Share
3.330.12-1.28-1.86-2.09-0.02
Cash Income Tax Paid
287.79266.04234.46162.48158.27131.95
Levered Free Cash Flow
--14.76-627.38-671.36-806.6730.77
Unlevered Free Cash Flow
-86.49-544.33-622.62-782.732.59
Change in Working Capital
-419.81-419.81-849.92-993.4-1,013-226.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.